Skip to content
snus freak!
18+ only
Nicotine Pouches

Nicotine pouch absorption: how fast it hits and how long it lasts

by Jose Del Pozo 12 min read
Dark graphic with three stacked white pouch shapes beside the headline 'Nicotine pouch absorption: how fast it hits and how long it lasts'.

Plasma nicotine rises for as long as the pouch is in your lip, and peaks at or just after the moment you take it out. Nicotine’s own half-life is one to two hours, and you are close to baseline around five hours after removal. Cotinine, the thing a test looks for, lasts fifteen to twenty hours.

Almost every argument about pouch “strength” is really an argument about absorption, and it goes wrong because three completely different clocks get mixed together: how long the pouch keeps delivering, how long nicotine stays in your blood, and how long a biomarker remains detectable. Those are 20–60 minutes, a couple of hours, and most of a day respectively. Separating them answers most of the questions people actually have.

Everything below is from a primary source and I have flagged the funding on each, because the literature here is overwhelmingly industry-paid and the one independent study disagrees with the industry ones in an instructive way.

Clock one: the pouch is still working when you take it out

This is the finding that surprises people, and it is remarkably consistent across studies that share nothing else. Time to peak plasma nicotine tracks the hold time almost exactly:

  • 20-minute hold — Johns Hopkins, NIDA-funded, 28 participants, double-blind: peak at 22–26 minutes across six pouch arms.
  • 30-minute hold — Philip Morris, 31 participants: peak at roughly 34–36 minutes for every arm, including ZYN Cool Mint Mini Dry and VELO Ice Cool.
  • 60-minute hold — Lunell et al. 2020, manufacturer-financed, as reproduced by BfR: peak at 59–69 minutes.

RIVM states the mechanism plainly, summarising the same study: “Lunell et al. (2020) rapporteerden dat de plasma nicotineconcentraties continue stegen tijdens het gebruik en dat de hoogste concentraties aan het eind van de gebruiksperiode werden bereikt” — concentrations rose continuously during use and the highest were reached at the end of the use period.

So a pouch is not like a cigarette, where the peak arrives in minutes and then falls. It is closer to a slow intravenous line that you switch off by hand. Which means hold time is not a comfort setting. It is the dose control.

What the numbers actually are

Here is the published human pharmacokinetic literature on tobacco-free pouches, as tabulated by the BfR-funded team in Frontiers in Pharmacology, with their own warning attached.

Study Highest strength, mg Hold, min Highest mean Cmax Highest mean AUC0–t Last sample Funding
Mallock-Ohnesorg 2024 30 20 29.4 ng/mL 45.7 ng/mL × h 4 h BfR (independent)
Lunell 2020 8 60 18.5 ng/mL 58.4 ng/mL × h 6 h Swedish Match
McEwan 2022 10 60 18.4 ng/mL 53.7 ng/mL × h 6 h BAT
Rensch 2021 4 30 12.1 ng/mL 19.5 ng/mL × h 3 h industry
Chapman 2022 10 20 7.9 ng/mL 18.4 ng/mL × h 8 h Imperial Brands
Azzopardi 2022 4 60 8.5 ng/mL 29.7 ng/mL × h 8 h Imperial Tobacco Canada / BAT

The authors’ caveat, verbatim: “It should be noted that the last blood sampling time point (t) has a large influence on the AUC0–t and that it varied across the studies mentioned in Table 3. Thus, the different AUC0–t values should be compared with caution.” Do not rank those AUC figures against each other. Note also that the table’s Cmax cell for Azzopardi is the pouch figure of 8.5 ng/mL from the paper itself; the summary tables in both BfR and Frontiers carry 8.3, which is that study’s lozenge comparator.

Two things stand out. Thirteen of the fifteen pouch pharmacokinetic studies registered on ClinicalTrials.gov are sponsored by companies that sell pouches; the exceptions are a Johns Hopkins study funded by NIDA under grant 1R01DA055962-01, and the BfR work above. BfR says the same thing about its own summary table in plain German: the first five studies in it were conducted by or with the support of manufacturers.

Why “a 6 mg pouch” has no single answer

Compare two figures for the same label strength. The manufacturer-financed study held a 6 mg pouch for sixty minutes and measured a mean peak of 14.7 ng/mL. The independent BfR study held a different maker’s 6 mg pouch for twenty minutes and measured 2.8 ng/mL. That is a 5.3-fold difference for the same number on the can, and both figures are in BfR-linked primary documents.

Hold time explains most of it and brand explains the rest. Which is why I would not quote any single row of that table as “what a 6 mg pouch does” — it is what one product did under one protocol.

The independent study also kills the assumption that dose scales. Mallock-Ohnesorg and colleagues analysed what was actually in the pouches they dosed — “Analyzed nicotine contents were 4.8 ± 0.4 mg, 16.3 ± 3.1 mg, and 27.1 ± 0.2 mg for the nicotine pouches declared with 6, 20, and 30 mg” — and then measured relative bioavailability. Their conclusion, verbatim:

“Results of the herein presented study also speak against a linear relationship between nicotine delivery and nicotine content in the pouch, visible in the relative bioavailability ranging from 70% to 165%. Also, the Cmax does not increase proportionally with the nicotine content. This is likely due to different nicotine releases from the pouches.”

Funding and conflicts on that one, for completeness: “The study was funded by intermural funding from the German Federal Institute for Risk Assessment (BfR), grant No. BfR-CPS-08-60-0102-02.P606”, and “The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.” The typo “intermural” is theirs.

How much is left in the pouch when you spit it out

Extraction fraction is the bridge between the number on the can and the number in your blood, and it moves with duration. Assembled from primary sources, with the funder named because every figure here comes from someone with an interest except the BfR rows:

Hold Product Extracted Source / funder
15 min ZYN Dry Smooth 6 mg 17.1 ± 7.8% Knopp 2022 / Swedish Match
15 min General snus 8 mg 8.0 ± 3.3% Knopp 2022 / Swedish Match
20 min pouch, 6 mg declared 38% Mallock-Ohnesorg 2024 / BfR
20 min pouch, 20 mg declared 24% Mallock-Ohnesorg 2024 / BfR
20 min pouch, 30 mg declared 52% Mallock-Ohnesorg 2024 / BfR
20 min ZoneX #2, 5.8 mg 13.5 ± 5.3% NCT04891406 / Imperial Brands
60 min ZYN 3 / 6 / 8 mg 55.9 / 59.1 / 50.4% Lunell 2020 via BfR / Swedish Match
60 min ZYN Dry Smooth 6 mg 56.0 ± 18.1% Knopp 2022 / Swedish Match
60 min BAT Peppermint 4 mg 62% Azzopardi 2022 / BAT
60 min General snus 8 mg 31.8 ± 10.8% Knopp 2022 / Swedish Match
60 min American moist snuff 18 mg 18.9% Lunell 2020 via BfR / Swedish Match

Two readings. First, the extraction figures are nowhere near 100% even after an hour — roughly half the nicotine goes in the bin. Second, they are not monotonic in dose: 38%, 24% and 52% for 6, 20 and 30 mg in the same study, same subjects, same protocol. Anyone who tells you a 20 mg pouch delivers three times a 6 mg pouch is guessing.

RIVM gives the cleanest single sentence on duration, independent and quotable: “De opname van nicotine is afhankelijk van de gebruiksduur van de nicotinezakjes. Na een gebruiksduur van 30 minuten waren de nicotineconcentraties in plasma gelijk aan of iets hoger dan de helft van de concentratie na 60 minuten.” Thirty minutes gets you a bit over half of what sixty gets you. RIVM also notes the between-person spread in released nicotine runs about 45–65%.

And the release side of it varies by product independently of all this. BfR’s own in-vitro work on fifteen pouches found that “In four out of 15 samples, more than 70% of the total nicotine content was released in the first 5 minutes”, while “seven other samples released less than 60% of the nicotine they contained within the first 10 minutes” — concluding that “most of the nicotine is released within the first 20 minutes.” That is why two cans at the same strength behave differently, which I have taken apart separately in why two 6 mg pouches from different brands feel completely different.

Clock two: how long nicotine stays in your blood

This part is settled pharmacology and does not depend on the product. FDA-approved prescribing information for nicotine products states that “The apparent elimination half-life of nicotine is 1 to 2 hours”, that “The average plasma clearance is about 1.2 L/min in a healthy adult smoker”, and that “About 10% of the nicotine absorbed is excreted unchanged in the urine.”

The pouch studies measure it directly and land slightly higher, which is normal for a slowly absorbed product: 2.4, 2.2 and 1.8 hours across the three pouch arms in the independent study, with “no differences between study arms”; 2.7 ± 0.77 hours in Azzopardi’s pouch arm; and 109 to 152 minutes across the pouch rows in BfR’s table.

For when you are actually back to normal, RIVM: “Vijf uur na beëindiging van de blootstelling was de plasma nicotineconcentratie voor alle blootstellingen weer bijna terug op het niveau van voor de blootstelling.” Five hours after you stop, plasma nicotine is nearly back to where it started.

Clock three: how long it is detectable

Different question, different answer, and the gap is an order of magnitude. From the same FDA-approved label: “More than 20 metabolites of nicotine have been identified, all of which are less active than the parent compound. The primary urinary metabolites are cotinine (15% of the dose) and trans-3-hydroxycotinine (45% of the dose). Cotinine has a half-life of 15 to 20 hours and concentrations that exceed nicotine by 10-fold.”

So the biomarker outlives the drug by roughly ten times in both duration and concentration. I could not find any regulator or primary study giving a detection window in days after pouch use specifically, so I am not going to invent one — if you need a number for a test, the honest answer is that it depends on the assay, the cut-off and how much you use.

The second pouch of the day is not like the first

Here I have to be careful, because no repeated-dose pharmacokinetic study of nicotine pouches has been published. Every pouch study above is single-dose. The nearest primary evidence is nicotine gum, and RIVM summarises it: in a 12-hour experiment with 39 experienced smokers taking gum hourly, a single dose peaked at 10 ng/mL (4 mg) or 14 ng/mL (6 mg), but the trough level before each new dose climbed for about nine hours to a steady state of 19–31 ng/mL depending on the regimen, with the final exposure of the day reaching 31–43 ng/mL.

That is gum, not pouches, and it must be read as such. But the mechanism is not product-specific: the first dose of the day sits on a near-zero baseline, and later doses sit on a rising floor. The absolute level goes up through the day while the felt increment goes down. If your fourth pouch feels weaker than your first, that is the likeliest explanation, and reaching for a stronger can is the wrong response to it. On stepping the other way, see how to step down your strength safely.

Context for daily totals, both industry-sourced: BfR reports an average of 8.6 pouches per day, RIVM about 10 to 12 for ZYN users.

What you can actually control

Hold time, and not much else. FDA’s own review of real-world ZYN use found that use diverges sharply from the label: “Misuse of the new products (i.e., being used in ways other than intended based on product labeling) was common among current U.S. users, including longer durations of use (80.7% reporting using the product >60 minutes always or sometimes), using more than one pouch (29.2% reporting using one pouch at a time only sometimes or never), and inappropriate placement in the mouth (44% reporting placement between the gum and upper lip only sometimes or never).”

Against that, the makers’ advice converges on about half an hour. ZYN UK says “we recommend using the pouch for up to 30 minutes”; VELO notes that “Most users keep a pouch in for between 20–40 minutes” and that it “recommends keeping a pouch in place for around 30 minutes”; RIVM found advice across the market spanning “minimaal 5 minuten tot maximaal 1 uur”. BfR’s observation is the useful one: some makers “recommend significantly shorter application times of 20 to 30 minutes, from which it can be assumed that less nicotine will be absorbed.”

If you want less, take it out sooner — at thirty minutes you get a bit over half of the hour’s delivery, with a clean primary source behind that figure. If you want it faster rather than more, that is a pH and formulation question rather than a timing one, and it lives in pouch pH and why it changes the hit. And if you simply want to know how long to leave one in, I have answered that directly in how long should you keep a nicotine pouch in?

FAQ

How fast does a pouch hit? You will notice the tingle within a minute or two, but that is sensation, not nicotine. Measured plasma nicotine climbs throughout the hold and peaks at the end of it. Compare a disposable vape, where an independent BfR-funded crossover measured a peak at 5–6 minutes and a cigarette at 8 minutes. A pouch takes four to ten times longer to peak.

Does it last longer than a cigarette? The delivery does, because it continues for as long as the pouch is in. Elimination does not: nicotine’s half-life was statistically indistinguishable across pouches, snus and cigarettes in the independent study.

Why does a bigger number not give a bigger hit? Because the pouch has to release the nicotine and your mucosa has to absorb it, and both vary by product. The independent study measured relative bioavailability from 70% to 165% across three strengths.

Is the peak the same if I use two at once? Nobody has published pouch data on that. The closest primary figure is from snus, where two 8 mg portions used together gave a peak of 21.2 ng/mL against 10.6 for one — roughly double, and the extraction fraction barely moved. Treat it as indicative of snus and not as a pouch measurement.

Does flavour change absorption? On the available evidence, no. The Johns Hopkins study found tobacco, mint and fruit arms indistinguishable at matched strength, dose did all the work, and FDA’s review states that its bioequivalence analysis “demonstrated nicotine exposure was unlikely to differ across products with the same nicotine content but different characterizing flavors” — though that finding is within one manufacturer’s range, not across brands.

Sources

Last verified 16 October 2026.

Nicotine is addictive. No tobacco or nicotine product is safe, and completely stopping is the lowest-risk option. This site is for adults who already use nicotine — 21+ in the United States, 18+ or your local legal age elsewhere. Nothing here is medical advice.

Read this next